enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Fluticasone/salmeterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone/salmeterol

   In 2012, Advair was part of a larger civil settlement agreement between GlaxoSmithKline (GSK) and the United States, in which GSK agreed to pay $1.043 billion; the United States said that GSK promoted off-label uses of Advair and paid kickbacks to healthcare professionals to sell this drug, among others. [19]

3. Mylan - Wikipedia

   en.wikipedia.org/wiki/Mylan

   Generic Advair agreement [ edit ] In 2011, the company entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic equivalent to GlaxoSmithKline 's Advair (US)/Seretide (UK) Diskus incorporating Pfizer's proprietary dry powder inhaler delivery platform. [ 56 ]

4. 2 Companies Suffering From Generic Competition and 1 ... - AOL

   www.aol.com/news/2013-10-04-2-companies...

   So far, GlaxoSmithKline has managed to confound generic competitors trying to copy its Advair treatment, the company's best-selling lung drug. However, this could soon be about to change after the ...

5. Prasco Laboratories - Wikipedia

   en.wikipedia.org/wiki/Prasco_Laboratories

   Prasco has licensed generic versions of a variety of brand-name prescription drugs, including the antihistamine Allegra, [3] [4] progestin Cyclessa (used in combined oral contraceptive pills), [5] the insomnia medication Ambien, GERD medication Protonix, Advair Diskus, and others allowing them to be the leading authorized generic company with ...

6. Could a Pair of Respiratory Disease Treatments Save ... - AOL

   www.aol.com/news/2013-09-16-could-a-pair-of...

   Like Advair, the patents for the medication will expire earlier (2014-2018) than those for the devices. That hasn't stopped Teva from also trying its hand at producing a generic version, however.

7. Glaxo Underperforms Industry in a Year: What's in Store? - AOL

   www.aol.com/news/glaxo-underperforms-industry...

   Shares of Glaxo (GSK) lag the industry in a year as generic erosion of some drugs mainly its top-selling drug, Advair offsets strong sales of new drugs.